Accuracy of Corneal Astigmatism in Different Region Modes

December 6, 2023 updated by: A-Yong Yu, Wenzhou Medical University
To analyze the difference between measured total corneal astigmatism and actual corneal astigmatism under different region modes and optimize the region setting.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

70

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Zhejiang
      • Wenzhou, Zhejiang, China, 325000
        • Recruiting
        • Eye Hispital of Wenzhou Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who received cataract surgery in The Eye Hospital of Wenzhou Medical University

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Patients who had received phacoemulsification surgery with or without implantation of toric IOL are with a certain amount of corneal astigmatism.
  • Best corrected visual acuity ≥ 0.66 (20/30 Snellen)

Exclusion Criteria:

  • Corneal diseases or severe irregular astigmatism (e.g., pterygium, keratoconus), existence of corneal opacification;
  • Ocular disease which may affect visual acuity (e.g., glaucoma, uveitis, retinal disease, pathologic myopia);
  • History of ocular surgery or ocular trauma before this cataract surgery;
  • Decentration of IOL > 0.3mm or tilt > 5°
  • Implantation of multifocal IOL
  • history of wearing of rigid contact lens within the past 4 weeks or soft contact lens within 1 week;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patients with corneal astigmatism
Patients who had received phacoemulsification surgery with or without implantation of toric IOL are with a certain amount of corneal astigmatism.
The total corneal astigmatism, anterior chamber depth, will be measured by a Scheimpflug tomographer. Pupil size will be measured by itrace device and MONCV3 device. Residual astigmatism will be tested by subjective refraction.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vectorial difference
Time Frame: ≥1 month after surgery
The vectorial difference between measured corneal astigmatism (under multiple different region mode settings) and actual corneal astigmatism.
≥1 month after surgery
pupil size
Time Frame: ≥1 month after surgery
pupil size of patients in a bright environment measured by itrace device and MONCV3 device
≥1 month after surgery
pupil size 2
Time Frame: ≥1 month after surgery
pupil size of patients measured by Pentacam HR device
≥1 month after surgery
residual astigmatism
Time Frame: ≥1 month after surgery
residual astigmatism tested by subjective refraction
≥1 month after surgery
total corneal astigmatism
Time Frame: ≥1 month after surgery
Total corneal astigmatism measured by a scheimpflug tomographer under different region mode settings.
≥1 month after surgery
Anterior chamber depth
Time Frame: ≥1 month after surgery
The distance between corneal apex and anterior surface of IOL measured by a scheimpflug tomographer
≥1 month after surgery
actual corneal astigmatism
Time Frame: ≥1 month after surgery
actual corneal astigmatism is derived from residual astigmatism at corneal plane and cylindrical power of IOL at corneal plane through Holladay 2 formula.
≥1 month after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: AYong Yu, MD.PhD., Wenzhou Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 10, 2017

Primary Completion (Estimated)

June 10, 2024

Study Completion (Estimated)

October 28, 2024

Study Registration Dates

First Submitted

September 27, 2017

First Submitted That Met QC Criteria

September 27, 2017

First Posted (Actual)

October 3, 2017

Study Record Updates

Last Update Posted (Estimated)

December 7, 2023

Last Update Submitted That Met QC Criteria

December 6, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017ASTIGMATISM REGIONS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Astigmatism

Clinical Trials on patients with corneal astigmatism

3
Subscribe